Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.00
Bid: 261.80
Ask: 262.20
Change: -1.60 (-0.61%)
Spread: 0.40 (0.153%)
Open: 263.40
High: 263.80
Low: 260.60
Prev. Close: 263.60
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme Effective and Admission

28 May 2019 08:31

RNS Number : 3027A
Man Group plc
28 May 2019
 

SCHEME EFFECTIVE AND ADMISSION

 

Man Group plc (UK) (company number 08172396) /

Man Group plc (Jersey) (company number 127570)

28 May 2019

Corporate Reorganisation - Scheme Effective Date, De-Listing of Man ordinary shares and Listing of New Man ordinary shares

Man Group plc (registered in England and Wales under company number 08172396) (Man) and Man Group plc (registered in Jersey under company number 127570) (New Man) announce that the Court Order relating to the Scheme and the related Man Statement of Capital have now been delivered to the Registrar of Companies in England and Wales. Accordingly, the Scheme has become effective today and New Man is now the holding company of the Group.

Under the Scheme, Man Shareholders (who were on the register at the Scheme Record Time) received one New Man Ordinary Share for each Man Ordinary Share held at the Scheme Record Time. Therefore, as at the date of this announcement, the total issued ordinary share capital of New Man is 1,541,794,770 ordinary shares of 33/7 US cents each.

New Man also confirms that the listing of the Man Ordinary Shares on the Official List was cancelled and the Man Ordinary Shares ceased to be admitted to trading on the London Stock Exchange's main market for listed securities with effect from 8.00 a.m. today.

The New Man Ordinary Shares with a nominal value of 33/7 US cents each, have been admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities at 8.00 a.m. today.

New Man Ordinary Shares held in uncertificated form were credited to the relevant CREST accounts on or prior to 8.00 a.m. today. Share certificates in respect of New Man Ordinary Shares held in certificated form are expected to be despatched to shareholders by 11 June 2019.

The new ISIN number for the New Man Ordinary Shares is JE00BJ1DLW90. New Man will have the same ticker symbol as Man, which will therefore remain as EMG.

Further to the announcement on 10 May 2019, New Man confirms that it has entered an irrevocable, non-discretionary arrangement with J.P. Morgan Securities plc (JPMS plc) in order to enable the buy-back programme that was commenced by Man with JPMS plc in October 2018 to be completed. There is c. US$26.5 million outstanding under the share buy-back programme.

It is expected that the re-registration as a private limited company and change of name of Man from Man Group plc to Man Group Limited will take effect later today.

Capitalised terms used but not defined herein have the meanings given to them in the Prospectus published by New Man on 15 April 2019.

For further information:

 

Fiona Smart

Head of Investor Relations

+44 20 7144 2030

fiona.smart@man.com

 

Georgiana Brunner

Director of Communications

+44 20 7144 1000

media@man.com

 

Michael Turner

Finsbury

+44 20 7251 3801

mangroupUK@finsbury.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SOASEUSWAFUSEEI
Date   Source Headline
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20211:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
30th Jul 20211:25 pmGNWMan Group PLC : Form 8.3 - St.Modwen Properties plc
30th Jul 20211:20 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.